Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Med Rep ; 20(3): 2867-2874, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31322238

ABSTRACT

The present study aimed to investigate whether apigenin elicits antidepressant effects in depressant­like mice via the regulation of autophagy. The depressant­like behaviors were established in a chronic restraint stress model. Male BALB/c mice were subjected to restraint stress for 6 h/day for a period of 21 days, and deficits in sucrose preference, tail suspension and forced swim tests were confirmed to be improved following oral apigenin. To investigate the underlining mechanisms, the hippocampal levels of p62 and microtubule­associated protein light chain 3­II/I (LC3­II/I) were measured using western blot analysis. The expression levels of LC3­II/I and p62 indicated that the significantly inhibited autophagy level induced by chronic restraint stress can be increased following apigenin treatment. Similar to the level of autophagy, the expression levels of adenosine monophosphate­activated protein kinase (AMPK) and Unc­51 like autophagy activating kinase­1 were downregulated after chronic restraint stress stimulation and, subsequently upregulated following treatment with apigenin. Conversely, the levels of mammalian target of rapamycin (mTOR) were increased in chronic restraint stress mice and inhibited by apigenin. Collectively, the present findings indicated that apigenin potentially promotes autophagy via the AMPK/mTOR pathway and induces antidepressive effects in chronic restraint stress mice.


Subject(s)
Antidepressive Agents/therapeutic use , Apigenin/therapeutic use , Autophagy/drug effects , Depression/drug therapy , Signal Transduction/drug effects , AMP-Activated Protein Kinase Kinases , Animals , Antidepressive Agents/pharmacology , Apigenin/pharmacology , Autophagy-Related Protein-1 Homolog/metabolism , Depression/metabolism , Male , Mice, Inbred BALB C , Protein Kinases/metabolism , TOR Serine-Threonine Kinases/metabolism
2.
Sci Rep ; 7(1): 455, 2017 03 28.
Article in English | MEDLINE | ID: mdl-28352125

ABSTRACT

Chronic renal failure (CRF) is a major public health problem worldwide. Hydrogen sulfide (H2S) plays important roles in renal physiological and pathophysiological processes. However, whether H2S could protect against CRF in rats remains unclear. In this study, we found that H2S alleviated gentamicin-induced nephrotoxicity by reducing reactive oxygen species (ROS)-mediated apoptosis in normal rat kidney-52E cells. We demonstrated that H2S significantly improved the kidney structure and function of CRF rats. We found that H2S decreased the protein levels of Bax, Caspase-3, and Cleaved-caspase-3, but increased the expression of Bcl-2. Treatment with H2S reduced the levels of malondialdehyde and ROS and increased the activities of superoxide dismutase and glutathione peroxidase. H2S significantly abolished the phosphorylation of extracellular signal-regulated protein kinase 1/2, c-Jun N-terminal kinase, and p38 in the kidney of CRF rats. Furthermore, H2S decreased the expression levels of tumor necrosis factor-α, interleukin (IL)-6, IL-10, and monocyte chemoattractant protein-1, as well as the protein levels of p50, p65, and p-p65 in the kidney of CRF rats. In conclusion, H2S could ameliorate adenine-induced CRF in rats by inhibiting apoptosis and inflammation through ROS/mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways.


Subject(s)
Apoptosis/drug effects , Hydrogen Sulfide/pharmacology , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Reactive Oxygen Species/metabolism , Renal Insufficiency, Chronic/metabolism , Signal Transduction/drug effects , Animals , Biomarkers , Cell Line , Cell Proliferation/drug effects , Disease Models, Animal , Immunohistochemistry , Kidney Function Tests , Male , Oxidative Stress/drug effects , Protective Agents/pharmacology , Rats , Renal Insufficiency, Chronic/drug therapy , Renal Insufficiency, Chronic/etiology , Renal Insufficiency, Chronic/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...